NCT00488306View on ClinicalTrials.gov

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

August 31, 2007

Conditions
Abdominal Abscess
Interventions
DRUG

tigecycline

Trial Locations (1)

Unknown

Multiple Cities

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00488306 - Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI | Biotech Hunter | Biotech Hunter